Cas9 Proofreads Gene Edits

The gene-editing CRISPR/Cas9 system has three checkpoints to ensure it alters the right section of DNA.

Written byKaren Zusi
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

FLICKR, CAROLINE DAVISCRISPR/Cas9, now widely used as a precise way to edit DNA, involves the Cas9 protein locating pre-programmed sequences of base pairs before slicing and dicing the genome. Two recent reports, one published in Nature (October 28) and the other in Science (November 12), unveil details about how Cas9 ensures it targets the right sequences.

In the Science paper, CRISPR pioneer Jennifer Doudna from the University of California, Berkley, and her colleagues explored how the Cas9 protein searches for a single pattern of base pairs in an entire genome. Cas9 operates in conjunction with an RNA, programmed to guide Cas9 to a specific 20-nucleotide section of DNA. “It’s crazy that the Cas9 complex manages to scan the vast space of eukaryotic genomes,” study coauthor Spencer Knight of Berkeley said in a press release.

The team visualized Cas9’s binding patterns with single-particle tracking, finding that once the protein recognizes a primer sequence in the DNA, it will bind to incorrect areas that look like its actual target—but Cas9 tends to disengage from these mistakes in less than a second. These steps ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies